Source: International Congress 2016 – Features and impact of comorbidities in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Xiaoyue Wang (Nanjing, China), Xiaoyue Wang, Jiadi Chen, Peili Sun, Mao Huang. LATE-BREAKING ABSTRACT: Circulating YKL-40 level in COPD patients and their correlations with clinical parameters. Eur Respir J 2016; 48: Suppl. 60, 655

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Plasma homocysteine is associated with low diffusion capacity (DLCO) in COPD patients Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 LATE-BREAKING ABSTRACT: Cytokines and MMP 9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: Annual Congress 2012 - Respiratory diseases at at work: epidemiology, inflammation and challenge studies Year: 2012 LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 LATE-BREAKING ABSTRACT: Elevated cardiovascular risk as measured by QRISK2 score in patients hospitalized for acute COPD exacerbation versus stable COPD outpatients Source: International Congress 2014 – Comorbidities Year: 2014 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 LATE-BREAKING ABSTRACT: Large differences in rate of reported and unreported COPD exacerbations in Japanese patients; data from the COSMOS-J trial Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Gender differences in plasma biomarkers levels in patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 LATE-BREAKING ABSTRACT: Plasma MMP-9 is related to a bronchitic COPD phenotype–report from the obstructive lung disease in northern Sweden (OLIN) studies Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 LATE-BREAKING ABSTRACT: Predictive factors of frequent exacerbations in mild grade COPD patients Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: Stability of blood eosinophil count in COPD patients in the UK clinical practice research datalink Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 LATE-BREAKING ABSTRACT: An algorithm for the identification of clinical COPD phenotypes in daily practice Source: International Congress 2016 – COPD diagnosis and management Year: 2016